Please login to the form below

Not currently logged in
Email:
Password:

cilengitide

This page shows the latest cilengitide news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Another angiogenesis inhibitor, cilengitide, is in phase 3 development in Germany and the US in combination with temozolomide and radiation therapy, in newly diagnosed patients, and phase 2 in Germany in

Latest news

  • Merck KGaA forges clinical alliance with Quintiles Merck KGaA forges clinical alliance with Quintiles

    Moreover It has suffered a number of late-stage pipeline disappointments of late, including failures for brain and lung cancer prospect cilengitide and cladribine for multiple sclerosis.

  • Merck KGaA to meet 2014 financial targets one year early Merck KGaA to meet 2014 financial targets one year early

    and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.

  • Late-stage failure for Merck’s cilengitide in brain cancer Late-stage failure for Merck’s cilengitide in brain cancer

    Merck KGaA has endured a pipeline setback with disappointing phase III results for its investigational brain cancer drug cilengitide. ... However, this has not proved the case for cilengitide in Merck's phase III CENTRIC (a) trial.

  • Cilengitide could promote tumour growth

    It was suggested that this could be a previously unknown characteristic of drugs similar to cilengitide. ... Results of the cilengitide study were published in the March 22 online issue of Nature Medicine.

  • Back on track

    Merck's Cilengitide has demonstrated promising results in a phase I trial and is currently undergoing phase II studies in the US. ... Cilengitide is a vitronectin (avï 3) inhibitor designed to inhibit angiogenesis.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics